Coronary artery vasoreactivity to intracoronary acetylcholine infusion test in patients with chest pain syndrome

Intern Med. 1992 Jan;31(1):22-7. doi: 10.2169/internalmedicine.31.22.

Abstract

Coronary vasoreactivity of patients with chest pain syndrome (CPS, 18 patients) was examined with intracoronary acetylcholine infusion test (ACh). For comparison, 10 patients with vasospastic angina (VSA) and 17 patients without chest pain (control group) were used. The luminal diameters of coronary arteries were measured before and after ACh, and the maximal value of constriction rate of each segment (MCR) was used as index of vasoreactivity in each patient. By the ACh test, an average MCR of 42 +/- 23% was observed in CPS, 84 +/- 17% in VSA, and 26 +/- 12% in the control group. In CPS, chest pain was induced by ACh in 7 patients (group I), but was not induced in the other 11 patients (group II). The average MCR of group I (66 +/- 18%) was significantly higher than group II (28 +/- 9%, p less than 0.01) and the control group (p less than 0.01), though lower than VSA (p less than 0.05). These findings suggest that increased coronary vasoreactivity may play an important role in the chest pain development in CPS.

Publication types

  • Comparative Study

MeSH terms

  • Acetylcholine* / administration & dosage
  • Adult
  • Aged
  • Angina Pectoris / diagnosis
  • Angina Pectoris / diagnostic imaging
  • Angina Pectoris / physiopathology
  • Chest Pain / diagnosis*
  • Chest Pain / diagnostic imaging
  • Chest Pain / physiopathology
  • Coronary Angiography
  • Coronary Vasospasm / diagnosis*
  • Coronary Vasospasm / diagnostic imaging
  • Coronary Vasospasm / physiopathology
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Syndrome
  • Vasoconstriction / drug effects

Substances

  • Acetylcholine